作者
Ganpat Devpura, Balvir S Tomar, Deepak Nathiya, Abhishek Sharma, Deepak Bhandari, Swati Haldar, Acharya Balkrishna, Anurag Varshney
发表日期
2021/4/1
期刊
Phytomedicine
卷号
84
页码范围
153494
出版商
Urban & Fischer
简介
Background
Specific treatment for COVID-19 is still an unmet need. Outcomes of clinical trials on repurposed drugs have not been yielding success. Therefore, it is necessary to include complementary approaches of medicine against COVID-19.
Purpose
This study was designed to evaluate the impact of traditional Indian Ayurvedic treatment regime on asymptomatic patients with COVID-19 infection.
Study design
It is a placebo controlled randomized double-blind pilot clinical trial.
Methods
The study was registered with Clinical Trial Registry-India (vide Registration No. CTRI/2020/05/025273) and conducted at the Department of Medicine in National Institute of Medical Sciences and Research, Jaipur, India. 1 g of Giloy Ghanvati (Tinospora cordifolia) and 2 g of Swasari Ras (traditional herbo-mineral formulation) and 0.5 g each of Ashwagandha (Withania somnifera) and Tulsi Ghanvati (Ocimum sanctum) were given …
学术搜索中的文章
G Devpura, BS Tomar, D Nathiya, A Sharma… - Phytomedicine, 2021